Surgery Partners, Inc. (NASDAQ:SGRY) Shares Acquired by Deutsche Bank AG

Deutsche Bank AG increased its position in Surgery Partners, Inc. (NASDAQ:SGRY) by 20.4% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 96,512 shares of the company’s stock after purchasing an additional 16,340 shares during the period. Deutsche Bank AG owned 0.08% of Surgery Partners worth $2,043,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. AlphaCentric Advisors LLC acquired a new position in Surgery Partners in the fourth quarter worth about $374,000. Northern Trust Corp grew its stake in Surgery Partners by 2.1% in the fourth quarter. Northern Trust Corp now owns 761,790 shares of the company’s stock worth $16,127,000 after purchasing an additional 15,657 shares in the last quarter. Norges Bank acquired a new position in Surgery Partners in the fourth quarter worth about $15,796,000. E. Ohman J or Asset Management AB grew its stake in Surgery Partners by 40.3% in the fourth quarter. E. Ohman J or Asset Management AB now owns 1,243,111 shares of the company’s stock worth $26,317,000 after purchasing an additional 357,023 shares in the last quarter. Finally, Empowered Funds LLC acquired a new position in Surgery Partners in the fourth quarter worth about $245,000.

Analysts Set New Price Targets

A number of equities analysts recently commented on SGRY shares. Macquarie decreased their price target on Surgery Partners from $34.00 to $33.00 and set an “outperform” rating for the company in a research note on Tuesday, March 11th. Royal Bank of Canada reissued an “outperform” rating and issued a $35.00 target price on shares of Surgery Partners in a report on Tuesday, March 25th. Finally, Benchmark reissued a “buy” rating and issued a $35.00 target price on shares of Surgery Partners in a report on Monday, April 21st. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $34.75.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $22.60 on Friday. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The firm’s 50-day moving average price is $22.49 and its two-hundred day moving average price is $23.07. Surgery Partners, Inc. has a 52-week low of $19.50 and a 52-week high of $33.97. The stock has a market capitalization of $2.90 billion, a P/E ratio of -47.08, a P/E/G ratio of 19.21 and a beta of 1.96.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Monday, May 12th. The company reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.04). The business had revenue of $776.00 million for the quarter, compared to the consensus estimate of $777.77 million. Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The business’s quarterly revenue was up 8.2% on a year-over-year basis. During the same period last year, the firm posted $0.10 EPS. As a group, sell-side analysts forecast that Surgery Partners, Inc. will post 0.67 earnings per share for the current year.

Insider Activity

In other news, insider Marissa Brittenham sold 3,156 shares of Surgery Partners stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $24.09, for a total transaction of $76,028.04. Following the sale, the insider now owns 63,408 shares of the company’s stock, valued at approximately $1,527,498.72. The trade was a 4.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO David T. Doherty sold 6,733 shares of Surgery Partners stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $24.02, for a total value of $161,726.66. Following the sale, the chief financial officer now directly owns 150,868 shares in the company, valued at approximately $3,623,849.36. This trade represents a 4.27% decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.30% of the company’s stock.

Surgery Partners Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.